Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amgen, Inc.

http://www.amgen.com

Latest From Amgen, Inc.

C&D Expands Oral Care Portfolio, Acquires TheraBreath Mouthwash Brand In Latest Deal

Church & Dwight anticipates 15% growth for TheraBreath mouthwash brand in 2022 on larger sizes and wider distribution, especially outside US. It plans to acquire the firm for around $580m cash and close the deal before end of year

M & A OTC Drugs

Krystal Sees Success With Topical Gene Therapy In Debilitating Rare Skin Disorder

A regulatory filing for Vyjuvek in the US is targeted for the first half of 2022 following the positive results of a Phase III trial, positioning Krystal for its first commercial launch.

Gene Therapy Dermatology

Employee’s Decoy Laptop Did Not Trick Pfizer Security, Trade Secret Suit Says

Pfizer alleges its associate director of statistics transferred 12,000 files from her company laptop ahead of move to Xencor. Company seeks a temporary restraining order to prevent her from disclosing confidential information, including information on Pfizer’s COVID-19 vaccine and monoclonal antibodies for treatment of cancer.

Intellectual Property Coronavirus COVID-19

Health Canada Ponders UK Model On Easing Biosimilar Study Requirements

Discussions are ongoing at Health Canada on the feasibility of adopting the UK model of easing clinical study requirements for biosimilars, said director general Celia Lourenco at a recent event. Meanwhile, the US FDA’s stance is unchanged for now.

Regulation Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abgenix
    • Amgen Astellas BioPharma K.K.
    • Amgen K.K.
    • Avidia
    • BioVex Group
    • Catherex, Inc.
    • deCODE Genetics
    • Dezima Pharma B.V.
    • Five Prime Therapeutics, Inc.
    • Ilypsa
    • Immunex Corporation
    • KAI Pharmaceuticals
    • Kirin-Amgen Inc.
    • Laboratorio Quimico Farmaceutico Bergamo Ltd
    • Micromet, Inc. (CancerVax Corporation)
    • Nuevolution AB
    • Nuevolution A/S
    • Onyx Pharmaceuticals, Inc. (Proteolix, Inc.)
    • Saga Investments LLC
    • Tularik
UsernamePublicRestriction

Register